CORRELATION BETWEEN HB1AC AND FASTING BLOOD GLUCOSE IN DIABETIC AND NON DIABETIC PERSON.
Main Article Content
Keywords
.........
Abstract
In 2014, the IDF(International diabetic federation) estimated that 8.2% of adults aged 20–79 (387 million people) were living with diabetes; this compares with 382 million people in 2013, and the number of people with the disease was projected to rise beyond 592 million in 2035.T1DM is a result of absolute insulin deficiency whereas insulin resistance and relative insulin deficiency are the key elements of T2 High concentrations of glucose can increase the glycation of common proteins such as hemoglobin, forming Hemoglobin A1c (HbA1c). DM. The aim and objective is to study the relationship of fasting blood glucose and HbA1c and to establish a conversion equation between them. This study was conducted on the type 2 diabetic outpatient attending the out-patient diabetes clinic of Department of Medicine, PIMS Udaipur. A total 50 patients history of type 2 diabetes mellitus was recruited for the study after obtaining the informed consent.
References
2. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care, 37, S81-S90.
3. Chowdhury, T. and Lasker, S. (1998) Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgraduate medical journal, 74, 480-481.
4. Control, Diabetes, Group, Complications, Trial, DCCT and Research (1995) Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. The American Journal of Cardiology, 75, 894-903.
1. Goode, K. M., John, J., Rigby, A. S., Kilpatrick, E. S., Atkin, S., Bragadeesh, T., Clark, A. L. and Cleland, J. G. (2009) Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. Heart, 95, 917-923.
2. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31(8): 1473-8.
3. Mohammadi A, Esmaeili N. Diabetes control and its relationship with HbA1c and blodd sugar. The Journal of Qazvin University of Med 2001; (16): 23-6.
4. .Ginde AA, Cagliero E, Nathan DM, Camargo CA, Jr. Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population. J Gen Intern Med 2008; 23(9): 1346-53.
5. Kabadi, U. M. (1988) Glycosylation of proteins: lack of influence of aging. Diabetes care, 11, 429-432.
6. Bruce, D. G., Chisholm, D. J., Storlien, L. H. and Kraegen, E. W. (1988) Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes, 37, 736-744.
7. Chahil, T. J. and Ginsberg, H. N. (2006) Diabetic dyslipidemia. Endocrinology and metabolism clinics of North America, 35, 491-510.
8. Colhoun, H. M., Betteridge, D. J., Durrington, P. N. et al. (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. The Lancet, 364, 685-69.
9. Kilpatrick ES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol 2008; 61(9): 977-82.
10. Rohlfing, C. L., Wiedmeyer, H.-M., Little, R. R., England, J. D., Tennill, A. and Goldstein, D. E. (2002) Defining the relationship between plasma glucose and HbA1c. Diabetes care, 25, 275-278.
11. Sato, K. K., Hayashi, T., Harita, N., Yoneda, T., Nakamura, Y., Endo, G. and Kambe, H. (2009) Combined measurement of fasting plasma glucose and A1c is effective for the prediction of type 2 diabetes. Diabetes Care, 32, 644-646.

